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Background:	  The	  combination	  of	  guidelines	  about	  the	  prevention	  of	  lymphoedema,	  exercise	  therapy	  
and	  manual	  lymph	  drainage	  (MLD)	  is	  more	  effective	  to	  prevent	  arm	  lymphoedema	  than	  alone	  
guidelines.	  The	  preventive	  effect	  of	  MLD	  on	  the	  development	  of	  lymphoedema	  has	  never	  been	  
investigated	  in	  a	  peer-­‐reviewed	  randomised	  controlled	  trial.	  
Objective:	  This	  single-­‐blinded	  randomised	  controlled	  trial	  aimed	  to	  compare	  the	  effect	  of	  a	  treatment	  
programme	  consisting	  of	  guidelines,	  exercise	  therapy	  and	  MLD	  (experimental	  group)	  and	  the	  same	  
programme	  without	  MLD	  (control	  group)	  on	  the	  development	  of	  breast	  cancer-­‐	  related	  
lymphoedema.	  
Methods:	  We	   included	   160	   breast	   cancer	   patients	  with	   a	   unilateral	   axillary	   dissection.	   All	   patients	  
were	  randomised	  into	  an	  experimental	  (N=79)	  or	  control	  group	  (N=81).	  Treatment	  started	  five	  weeks	  
after	   the	   axillary	   dissection	   on	   average.	   Patients	  were	   treated	   during	   20	  weeks.	   The	   experimental	  
group	  received	  29	  exercise	  therapy	  sessions	  and	  34	  MLD	  sessions	  and	  the	  control	  group	  received	  28	  
exercise	   therapy	   sessions.	   The	   assessors	   were	   blinded	   for	   the	   allocation	   to	   the	   groups.	   Primary	  
endpoint	  was	  incidence	  of	  arm	  lymphoedema	  at	  6	  and	  12	  months,	  defined	  as	  an	  increase	  of	  200	  ml	  
or	   more	   of	   the	   pre-­‐surgical	   value.	   Secondary	   outcome	   parameters	   were	   time	   to	   develop	  
lymphoedema,	  lymphoedema	  volume	  and	  patient’s	  quality	  life	  at	  3,	  6	  and	  12	  months	  post-­‐surgery.	  
Results:	   Four	   patients	   of	   the	   experimental	   group	   and	   2	   patients	   of	   the	   control	   group	  were	   lost	   to	  
follow-­‐up.	   Overall	   incidence	   rates	   for	   lymphoedema	   were	   comparable	   between	   the	   experimental	  
and	  control	  group	  both	  at	  6	  months	  (14%	  vs	  15%,	  odds	  ratio	  0.9	  [95%	  CI	  0.4	  to	  2.3];	  p=0.93)	  and	  at	  12	  
months	  (24%	  vs	  19%,	  odds	  ratio	  1.3	  [95%	  CI	  0.6	  to	  2.9];	  p=0.45).	  Time	  to	  develop	  lymphoedema	  was	  
comparable	   in	   the	  experimental	  and	  control	  group	   (log	   rank	  p>0.05).	  Both	  groups	  had	  3,	  6	  and	  12	  
months	   post-­‐surgery,	   a	   similar	   increase	   of	   the	   arm	   volume	   compared	   to	   the	   pre-­‐surgical	   level	  
(p>0.05)	  and	  a	  comparable	  mental	  and	  physical	  health-­‐related	  quality	  of	  life	  (p>0.05).	  
Conclusion:	  MLD	  additional	  to	  guidelines	  and	  exercise	  therapy	  is	  unlikely	  to	  have	  a	  medium	  to	  large	  
effect	  in	  the	  reduction	  on	  the	  number	  of	  breast	  cancer-­‐	  related	  arm	  lymphoedema	  at	  short-­‐term.	  
